Prospective cohort study for changes of metabolic measures during antipsychotic treatments in patients with schizophrenia and bipolar disorder

Prospective cohort study for changes of metabolic measures during antipsychotic treatments in patients with schizophrenia and bipolar disorder - Prospective cohort study for changes of metabolic measures during antipsychotic treatments in patients with schizophrenia and bipolar disorder (matSaB study)

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000009868

Enrollment

1200

Registered

2013-04-01

Start date

2013-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia, Bipolar disorder

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: -Patients with schizophrenia or bipolar disorder who will newly receive indicated antipsychotics -Patients who have the records of medical history in past 1 year -Patients whom written informed consent is obtained

Exclusion criteria

Exclusion criteria: -Patients who are participating in an investigational drug study -Patients who have or had diabetes

Design outcomes

Primary

Measure	Time frame
Changes in the frequency of subtypes based on monitoring guidance during one-year follow-up and difference in them among antipsychotics	—

Secondary

Measure	Time frame
Relationship between metabolic deterioration and clinical measures, and difference in them among antipsychotics	—

Countries

Japan

Contacts

Public ContactTakashi Miyakoshi

Hokkaido University Hospital Clinical Research and Medical Innovation Center

matSaB@pop.med.hokudai.ac.jp011-706-7735

Outcome results